nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCG2—Omeprazole—Barrett's esophagus	0.279	0.404	CbGbCtD
Dabrafenib—CYP2C8—Omeprazole—Barrett's esophagus	0.149	0.215	CbGbCtD
Dabrafenib—CYP3A4—Esomeprazole—Barrett's esophagus	0.102	0.148	CbGbCtD
Dabrafenib—ABCB1—Omeprazole—Barrett's esophagus	0.101	0.146	CbGbCtD
Dabrafenib—CYP3A4—Omeprazole—Barrett's esophagus	0.0604	0.0873	CbGbCtD
Dabrafenib—Polyp—Omeprazole—Barrett's esophagus	0.00463	0.0184	CcSEcCtD
Dabrafenib—Polyp—Esomeprazole—Barrett's esophagus	0.00463	0.0184	CcSEcCtD
Dabrafenib—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.00444	0.0176	CcSEcCtD
Dabrafenib—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.00444	0.0176	CcSEcCtD
Dabrafenib—Cyst—Omeprazole—Barrett's esophagus	0.00421	0.0167	CcSEcCtD
Dabrafenib—Cyst—Esomeprazole—Barrett's esophagus	0.00421	0.0167	CcSEcCtD
Dabrafenib—Nephritis interstitial—Esomeprazole—Barrett's esophagus	0.00417	0.0166	CcSEcCtD
Dabrafenib—Nephritis interstitial—Omeprazole—Barrett's esophagus	0.00417	0.0166	CcSEcCtD
Dabrafenib—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00368	0.0146	CcSEcCtD
Dabrafenib—Rash erythematous—Omeprazole—Barrett's esophagus	0.00368	0.0146	CcSEcCtD
Dabrafenib—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00368	0.0146	CcSEcCtD
Dabrafenib—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00368	0.0146	CcSEcCtD
Dabrafenib—Rigors—Esomeprazole—Barrett's esophagus	0.00345	0.0137	CcSEcCtD
Dabrafenib—Rigors—Omeprazole—Barrett's esophagus	0.00345	0.0137	CcSEcCtD
Dabrafenib—Bone disorder—Esomeprazole—Barrett's esophagus	0.00312	0.0124	CcSEcCtD
Dabrafenib—Bone disorder—Omeprazole—Barrett's esophagus	0.00312	0.0124	CcSEcCtD
Dabrafenib—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.0031	0.0123	CcSEcCtD
Dabrafenib—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.0031	0.0123	CcSEcCtD
Dabrafenib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00308	0.0122	CcSEcCtD
Dabrafenib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00308	0.0122	CcSEcCtD
Dabrafenib—SIK1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.003	0.0535	CbGpPWpGaD
Dabrafenib—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00296	0.0117	CcSEcCtD
Dabrafenib—Creatinine increased—Omeprazole—Barrett's esophagus	0.00296	0.0117	CcSEcCtD
Dabrafenib—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00282	0.0112	CcSEcCtD
Dabrafenib—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00282	0.0112	CcSEcCtD
Dabrafenib—LIMK1—RhoA signaling pathway—SLC9A1—Barrett's esophagus	0.00279	0.0498	CbGpPWpGaD
Dabrafenib—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00275	0.049	CbGpPWpGaD
Dabrafenib—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00256	0.0102	CcSEcCtD
Dabrafenib—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00256	0.0102	CcSEcCtD
Dabrafenib—Neoplasm—Omeprazole—Barrett's esophagus	0.00255	0.0101	CcSEcCtD
Dabrafenib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00255	0.0101	CcSEcCtD
Dabrafenib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00235	0.00933	CcSEcCtD
Dabrafenib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00235	0.00933	CcSEcCtD
Dabrafenib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00205	0.00815	CcSEcCtD
Dabrafenib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00205	0.00815	CcSEcCtD
Dabrafenib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00205	0.00812	CcSEcCtD
Dabrafenib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00205	0.00812	CcSEcCtD
Dabrafenib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00192	0.0076	CcSEcCtD
Dabrafenib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00192	0.0076	CcSEcCtD
Dabrafenib—Dry skin—Esomeprazole—Barrett's esophagus	0.00187	0.00744	CcSEcCtD
Dabrafenib—Dry skin—Omeprazole—Barrett's esophagus	0.00187	0.00744	CcSEcCtD
Dabrafenib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00187	0.00741	CcSEcCtD
Dabrafenib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00187	0.00741	CcSEcCtD
Dabrafenib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00186	0.00739	CcSEcCtD
Dabrafenib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00186	0.00739	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00184	0.00731	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00184	0.00731	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.0018	0.00716	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0018	0.00716	CcSEcCtD
Dabrafenib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00173	0.00688	CcSEcCtD
Dabrafenib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00173	0.00688	CcSEcCtD
Dabrafenib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00165	0.00656	CcSEcCtD
Dabrafenib—Neutropenia—Omeprazole—Barrett's esophagus	0.00165	0.00656	CcSEcCtD
Dabrafenib—Infestation—Omeprazole—Barrett's esophagus	0.00158	0.00625	CcSEcCtD
Dabrafenib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00158	0.00625	CcSEcCtD
Dabrafenib—Infestation—Esomeprazole—Barrett's esophagus	0.00158	0.00625	CcSEcCtD
Dabrafenib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00158	0.00625	CcSEcCtD
Dabrafenib—Renal failure—Esomeprazole—Barrett's esophagus	0.00155	0.00615	CcSEcCtD
Dabrafenib—Renal failure—Omeprazole—Barrett's esophagus	0.00155	0.00615	CcSEcCtD
Dabrafenib—Stomatitis—Omeprazole—Barrett's esophagus	0.00154	0.0061	CcSEcCtD
Dabrafenib—Stomatitis—Esomeprazole—Barrett's esophagus	0.00154	0.0061	CcSEcCtD
Dabrafenib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00153	0.00608	CcSEcCtD
Dabrafenib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00153	0.00608	CcSEcCtD
Dabrafenib—Haematuria—Esomeprazole—Barrett's esophagus	0.0015	0.00596	CcSEcCtD
Dabrafenib—Haematuria—Omeprazole—Barrett's esophagus	0.0015	0.00596	CcSEcCtD
Dabrafenib—Epistaxis—Esomeprazole—Barrett's esophagus	0.00149	0.0059	CcSEcCtD
Dabrafenib—Epistaxis—Omeprazole—Barrett's esophagus	0.00149	0.0059	CcSEcCtD
Dabrafenib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.0014	0.00554	CcSEcCtD
Dabrafenib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.0014	0.00554	CcSEcCtD
Dabrafenib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00139	0.00553	CcSEcCtD
Dabrafenib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00139	0.00553	CcSEcCtD
Dabrafenib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00139	0.00552	CcSEcCtD
Dabrafenib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00139	0.00552	CcSEcCtD
Dabrafenib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00139	0.0055	CcSEcCtD
Dabrafenib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00139	0.0055	CcSEcCtD
Dabrafenib—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00138	0.0245	CbGpPWpGaD
Dabrafenib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00132	0.00525	CcSEcCtD
Dabrafenib—Eye disorder—Omeprazole—Barrett's esophagus	0.00132	0.00525	CcSEcCtD
Dabrafenib—Immune system disorder—Omeprazole—Barrett's esophagus	0.00128	0.00507	CcSEcCtD
Dabrafenib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00128	0.00507	CcSEcCtD
Dabrafenib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00128	0.00506	CcSEcCtD
Dabrafenib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00128	0.00506	CcSEcCtD
Dabrafenib—Chills—Omeprazole—Barrett's esophagus	0.00127	0.00504	CcSEcCtD
Dabrafenib—Chills—Esomeprazole—Barrett's esophagus	0.00127	0.00504	CcSEcCtD
Dabrafenib—Alopecia—Omeprazole—Barrett's esophagus	0.00125	0.00496	CcSEcCtD
Dabrafenib—Alopecia—Esomeprazole—Barrett's esophagus	0.00125	0.00496	CcSEcCtD
Dabrafenib—Mental disorder—Omeprazole—Barrett's esophagus	0.00124	0.00492	CcSEcCtD
Dabrafenib—Mental disorder—Esomeprazole—Barrett's esophagus	0.00124	0.00492	CcSEcCtD
Dabrafenib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00123	0.00489	CcSEcCtD
Dabrafenib—Malnutrition—Omeprazole—Barrett's esophagus	0.00123	0.00489	CcSEcCtD
Dabrafenib—Back pain—Omeprazole—Barrett's esophagus	0.00119	0.00473	CcSEcCtD
Dabrafenib—Back pain—Esomeprazole—Barrett's esophagus	0.00119	0.00473	CcSEcCtD
Dabrafenib—Muscle spasms—Omeprazole—Barrett's esophagus	0.00118	0.0047	CcSEcCtD
Dabrafenib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00118	0.0047	CcSEcCtD
Dabrafenib—Vision blurred—Esomeprazole—Barrett's esophagus	0.00116	0.00461	CcSEcCtD
Dabrafenib—Vision blurred—Omeprazole—Barrett's esophagus	0.00116	0.00461	CcSEcCtD
Dabrafenib—Anaemia—Omeprazole—Barrett's esophagus	0.00114	0.00452	CcSEcCtD
Dabrafenib—Anaemia—Esomeprazole—Barrett's esophagus	0.00114	0.00452	CcSEcCtD
Dabrafenib—Leukopenia—Esomeprazole—Barrett's esophagus	0.0011	0.00437	CcSEcCtD
Dabrafenib—Leukopenia—Omeprazole—Barrett's esophagus	0.0011	0.00437	CcSEcCtD
Dabrafenib—SIK1—LKB1 signaling events—TP53—Barrett's esophagus	0.0011	0.0196	CbGpPWpGaD
Dabrafenib—SLCO1B1—Irinotecan Pathway—APC—Barrett's esophagus	0.0011	0.0195	CbGpPWpGaD
Dabrafenib—Cough—Omeprazole—Barrett's esophagus	0.00107	0.00426	CcSEcCtD
Dabrafenib—Cough—Esomeprazole—Barrett's esophagus	0.00107	0.00426	CcSEcCtD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00107	0.0191	CbGpPWpGaD
Dabrafenib—Hypertension—Esomeprazole—Barrett's esophagus	0.00106	0.00422	CcSEcCtD
Dabrafenib—Hypertension—Omeprazole—Barrett's esophagus	0.00106	0.00422	CcSEcCtD
Dabrafenib—Myalgia—Esomeprazole—Barrett's esophagus	0.00105	0.00416	CcSEcCtD
Dabrafenib—Arthralgia—Omeprazole—Barrett's esophagus	0.00105	0.00416	CcSEcCtD
Dabrafenib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00105	0.00416	CcSEcCtD
Dabrafenib—Myalgia—Omeprazole—Barrett's esophagus	0.00105	0.00416	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00104	0.00413	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00104	0.00413	CcSEcCtD
Dabrafenib—Dry mouth—Esomeprazole—Barrett's esophagus	0.00103	0.00407	CcSEcCtD
Dabrafenib—Dry mouth—Omeprazole—Barrett's esophagus	0.00103	0.00407	CcSEcCtD
Dabrafenib—ABCG2—Irinotecan Pathway—APC—Barrett's esophagus	0.00101	0.0181	CbGpPWpGaD
Dabrafenib—Infection—Esomeprazole—Barrett's esophagus	0.000999	0.00396	CcSEcCtD
Dabrafenib—Infection—Omeprazole—Barrett's esophagus	0.000999	0.00396	CcSEcCtD
Dabrafenib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000986	0.00391	CcSEcCtD
Dabrafenib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000986	0.00391	CcSEcCtD
Dabrafenib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000984	0.00391	CcSEcCtD
Dabrafenib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000984	0.00391	CcSEcCtD
Dabrafenib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000976	0.00387	CcSEcCtD
Dabrafenib—Skin disorder—Omeprazole—Barrett's esophagus	0.000976	0.00387	CcSEcCtD
Dabrafenib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000972	0.00386	CcSEcCtD
Dabrafenib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000972	0.00386	CcSEcCtD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000941	0.0168	CbGpPWpGaD
Dabrafenib—LIMK1—CDC42 signaling events—APC—Barrett's esophagus	0.000928	0.0165	CbGpPWpGaD
Dabrafenib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000916	0.00363	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000916	0.00363	CcSEcCtD
Dabrafenib—Insomnia—Omeprazole—Barrett's esophagus	0.000909	0.00361	CcSEcCtD
Dabrafenib—Insomnia—Esomeprazole—Barrett's esophagus	0.000909	0.00361	CcSEcCtD
Dabrafenib—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00088	0.0157	CbGpPWpGaD
Dabrafenib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000874	0.00347	CcSEcCtD
Dabrafenib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000874	0.00347	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000868	0.00344	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000868	0.00344	CcSEcCtD
Dabrafenib—Fatigue—Omeprazole—Barrett's esophagus	0.000867	0.00344	CcSEcCtD
Dabrafenib—Fatigue—Esomeprazole—Barrett's esophagus	0.000867	0.00344	CcSEcCtD
Dabrafenib—Constipation—Omeprazole—Barrett's esophagus	0.00086	0.00341	CcSEcCtD
Dabrafenib—Constipation—Esomeprazole—Barrett's esophagus	0.00086	0.00341	CcSEcCtD
Dabrafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.000851	0.0152	CbGpPWpGaD
Dabrafenib—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000849	0.0151	CbGpPWpGaD
Dabrafenib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000822	0.00326	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000822	0.00326	CcSEcCtD
Dabrafenib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000795	0.00315	CcSEcCtD
Dabrafenib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000795	0.00315	CcSEcCtD
Dabrafenib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000795	0.00315	CcSEcCtD
Dabrafenib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000795	0.00315	CcSEcCtD
Dabrafenib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000791	0.0141	CbGpPWpGaD
Dabrafenib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000791	0.0141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling of Hepatocyte Growth Factor Receptor—HGF—Barrett's esophagus	0.00077	0.0137	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000763	0.0136	CbGpPWpGaD
Dabrafenib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000741	0.00294	CcSEcCtD
Dabrafenib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000741	0.00294	CcSEcCtD
Dabrafenib—RAF1—Endothelins—SLC9A1—Barrett's esophagus	0.000738	0.0132	CbGpPWpGaD
Dabrafenib—BRAF—Bladder Cancer—CDKN2A—Barrett's esophagus	0.000723	0.0129	CbGpPWpGaD
Dabrafenib—Asthenia—Omeprazole—Barrett's esophagus	0.000721	0.00286	CcSEcCtD
Dabrafenib—Asthenia—Esomeprazole—Barrett's esophagus	0.000721	0.00286	CcSEcCtD
Dabrafenib—Pruritus—Esomeprazole—Barrett's esophagus	0.000711	0.00282	CcSEcCtD
Dabrafenib—Pruritus—Omeprazole—Barrett's esophagus	0.000711	0.00282	CcSEcCtD
Dabrafenib—BRAF—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000709	0.0126	CbGpPWpGaD
Dabrafenib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000688	0.00273	CcSEcCtD
Dabrafenib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000688	0.00273	CcSEcCtD
Dabrafenib—SIK1—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000685	0.0122	CbGpPWpGaD
Dabrafenib—Dizziness—Esomeprazole—Barrett's esophagus	0.000665	0.00264	CcSEcCtD
Dabrafenib—Dizziness—Omeprazole—Barrett's esophagus	0.000665	0.00264	CcSEcCtD
Dabrafenib—BRAF—Bladder Cancer—CXCL8—Barrett's esophagus	0.000655	0.0117	CbGpPWpGaD
Dabrafenib—Vomiting—Omeprazole—Barrett's esophagus	0.000639	0.00254	CcSEcCtD
Dabrafenib—Vomiting—Esomeprazole—Barrett's esophagus	0.000639	0.00254	CcSEcCtD
Dabrafenib—Rash—Esomeprazole—Barrett's esophagus	0.000634	0.00251	CcSEcCtD
Dabrafenib—Rash—Omeprazole—Barrett's esophagus	0.000634	0.00251	CcSEcCtD
Dabrafenib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000633	0.00251	CcSEcCtD
Dabrafenib—Dermatitis—Omeprazole—Barrett's esophagus	0.000633	0.00251	CcSEcCtD
Dabrafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.000632	0.0113	CbGpPWpGaD
Dabrafenib—Headache—Esomeprazole—Barrett's esophagus	0.00063	0.0025	CcSEcCtD
Dabrafenib—Headache—Omeprazole—Barrett's esophagus	0.00063	0.0025	CcSEcCtD
Dabrafenib—Nausea—Esomeprazole—Barrett's esophagus	0.000597	0.00237	CcSEcCtD
Dabrafenib—Nausea—Omeprazole—Barrett's esophagus	0.000597	0.00237	CcSEcCtD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000576	0.0103	CbGpPWpGaD
Dabrafenib—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000569	0.0101	CbGpPWpGaD
Dabrafenib—RAF1—Ion channel transport—ATP4A—Barrett's esophagus	0.000566	0.0101	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000536	0.00955	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000509	0.00907	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000507	0.00904	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000491	0.00874	CbGpPWpGaD
Dabrafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000487	0.00869	CbGpPWpGaD
Dabrafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000487	0.00869	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000467	0.00833	CbGpPWpGaD
Dabrafenib—BRAF—CDC42 signaling events—APC—Barrett's esophagus	0.000464	0.00827	CbGpPWpGaD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	0.000449	0.008	CbGpPWpGaD
Dabrafenib—BRAF—Bladder Cancer—TP53—Barrett's esophagus	0.000402	0.00717	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000388	0.00692	CbGpPWpGaD
Dabrafenib—RAF1—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000377	0.00673	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000371	0.00661	CbGpPWpGaD
Dabrafenib—RAF1—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000364	0.00648	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000361	0.00643	CbGpPWpGaD
Dabrafenib—RAF1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000351	0.00625	CbGpPWpGaD
Dabrafenib—RAF1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000341	0.00608	CbGpPWpGaD
Dabrafenib—RAF1—Ceramide signaling pathway—RELA—Barrett's esophagus	0.000339	0.00604	CbGpPWpGaD
Dabrafenib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000338	0.00602	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000333	0.00593	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000332	0.00591	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000326	0.00581	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of retinoblastoma protein—PPARG—Barrett's esophagus	0.000325	0.00579	CbGpPWpGaD
Dabrafenib—RAF1—CDC42 signaling events—APC—Barrett's esophagus	0.000321	0.00572	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—TP53—Barrett's esophagus	0.000321	0.00572	CbGpPWpGaD
Dabrafenib—RAF1—IL-3 Signaling Pathway—CXCL8—Barrett's esophagus	0.000314	0.0056	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000309	0.00551	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—HGF—Barrett's esophagus	0.000306	0.00545	CbGpPWpGaD
Dabrafenib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000305	0.00544	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000295	0.00525	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000291	0.00519	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000288	0.00514	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—HGF—Barrett's esophagus	0.000281	0.00501	CbGpPWpGaD
Dabrafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.00028	0.00499	CbGpPWpGaD
Dabrafenib—BRAF—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000279	0.00498	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000276	0.00492	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000274	0.00489	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.000273	0.00487	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000272	0.00485	CbGpPWpGaD
Dabrafenib—RAF1—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000266	0.00474	CbGpPWpGaD
Dabrafenib—RAF1—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000263	0.00468	CbGpPWpGaD
Dabrafenib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00026	0.00464	CbGpPWpGaD
Dabrafenib—RAF1—BCR signaling pathway—RELA—Barrett's esophagus	0.00026	0.00463	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000253	0.00452	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000251	0.00447	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000248	0.00442	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000247	0.0044	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000246	0.00438	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000245	0.00436	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000244	0.00435	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000237	0.00423	CbGpPWpGaD
Dabrafenib—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000231	0.00411	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.00023	0.00409	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000224	0.00399	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000219	0.0039	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000205	0.00366	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000204	0.00363	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000202	0.00359	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000197	0.00351	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—HGF—Barrett's esophagus	0.000194	0.00347	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000193	0.00344	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.00019	0.00338	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000188	0.00336	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—PPARG—Barrett's esophagus	0.000188	0.00334	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000185	0.00331	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000185	0.00329	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—APC—Barrett's esophagus	0.00018	0.00321	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—RELA—Barrett's esophagus	0.000177	0.00316	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000175	0.00313	CbGpPWpGaD
Dabrafenib—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000173	0.00308	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000172	0.00307	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000172	0.00306	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000171	0.00305	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000169	0.00302	CbGpPWpGaD
Dabrafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00016	0.00286	CbGpPWpGaD
Dabrafenib—RAF1—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000154	0.00274	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—RELA—Barrett's esophagus	0.000152	0.00271	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000152	0.0027	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.00015	0.00267	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGES—Barrett's esophagus	0.000145	0.00259	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000144	0.00256	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000143	0.00254	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—RELA—Barrett's esophagus	0.000141	0.00251	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HGF—Barrett's esophagus	0.000135	0.0024	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—RELA—Barrett's esophagus	0.000134	0.00239	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000133	0.00237	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000131	0.00234	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000128	0.00228	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000126	0.00224	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000125	0.00223	CbGpPWpGaD
Dabrafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000122	0.00217	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000121	0.00215	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000119	0.00213	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—RELA—Barrett's esophagus	0.000118	0.0021	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000114	0.00203	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000113	0.00202	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CYP26A1—Barrett's esophagus	0.00011	0.00196	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000109	0.00195	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000105	0.00188	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000105	0.00187	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—GAST—Barrett's esophagus	0.000104	0.00186	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000104	0.00185	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000101	0.0018	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SLC9A1—Barrett's esophagus	9.76e-05	0.00174	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGES—Barrett's esophagus	9.75e-05	0.00174	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.29e-05	0.00165	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGES—Barrett's esophagus	9.03e-05	0.00161	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GAST—Barrett's esophagus	8.91e-05	0.00159	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—HGF—Barrett's esophagus	8.88e-05	0.00158	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	8.73e-05	0.00156	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	8.27e-05	0.00147	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—RELA—Barrett's esophagus	8.13e-05	0.00145	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	8.12e-05	0.00145	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—SLC9A1—Barrett's esophagus	7.93e-05	0.00141	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—RELA—Barrett's esophagus	7.81e-05	0.00139	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP26A1—Barrett's esophagus	7.39e-05	0.00132	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TP53—Barrett's esophagus	7.2e-05	0.00128	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—SST—Barrett's esophagus	7.15e-05	0.00127	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	6.84e-05	0.00122	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.78e-05	0.00121	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SLC9A1—Barrett's esophagus	6.75e-05	0.0012	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.5e-05	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—PPARG—Barrett's esophagus	6.49e-05	0.00116	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.39e-05	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GAST—Barrett's esophagus	6.17e-05	0.0011	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SST—Barrett's esophagus	6.11e-05	0.00109	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.69e-05	0.00101	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	5.6e-05	0.000998	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.46e-05	0.000973	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SLC9A1—Barrett's esophagus	5.32e-05	0.000949	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—RELA—Barrett's esophagus	5.25e-05	0.000936	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	5.15e-05	0.000917	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	4.93e-05	0.000879	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGES—Barrett's esophagus	4.88e-05	0.00087	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HGF—Barrett's esophagus	4.66e-05	0.00083	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—RELA—Barrett's esophagus	4.64e-05	0.000827	CbGpPWpGaD
Dabrafenib—BRAF—Disease—APC—Barrett's esophagus	4.61e-05	0.000822	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—RELA—Barrett's esophagus	4.45e-05	0.000794	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.29e-05	0.000765	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	4.24e-05	0.000757	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SST—Barrett's esophagus	4.23e-05	0.000753	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	3.7e-05	0.000659	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARG—Barrett's esophagus	3.62e-05	0.000645	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—Barrett's esophagus	3.5e-05	0.000624	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—APC—Barrett's esophagus	3.23e-05	0.000576	CbGpPWpGaD
Dabrafenib—RAF1—Disease—APC—Barrett's esophagus	3.19e-05	0.000569	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.14e-05	0.000559	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.06e-05	0.000546	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	3.06e-05	0.000545	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.01e-05	0.000536	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TP53—Barrett's esophagus	2.98e-05	0.000531	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—Barrett's esophagus	2.85e-05	0.000507	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.79e-05	0.000497	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—RELA—Barrett's esophagus	2.7e-05	0.000482	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.67e-05	0.000475	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RELA—Barrett's esophagus	2.52e-05	0.00045	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.47e-05	0.00044	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARG—Barrett's esophagus	2.43e-05	0.000433	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—Barrett's esophagus	2.42e-05	0.000432	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—Barrett's esophagus	2.38e-05	0.000424	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.28e-05	0.000406	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARG—Barrett's esophagus	2.25e-05	0.000401	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APC—Barrett's esophagus	2.24e-05	0.000398	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—Barrett's esophagus	1.91e-05	0.000341	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.77e-05	0.000316	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RELA—Barrett's esophagus	1.75e-05	0.000311	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—Barrett's esophagus	1.65e-05	0.000293	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.64e-05	0.000293	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—Barrett's esophagus	1.46e-05	0.00026	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.4e-05	0.000249	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.22e-05	0.000217	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	1.1e-05	0.000196	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—Barrett's esophagus	1.01e-05	0.00018	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	9.57e-06	0.000171	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	7.5e-06	0.000134	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	5.9e-06	0.000105	CbGpPWpGaD
